Cargando…

Fluvoxamine for the treatment of COVID-19

Detalles Bibliográficos
Autores principales: Kim, Hyun, Manzi, Shannon, Gonzelez-Heydrich, Joseph, Picker, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846602/
https://www.ncbi.nlm.nih.gov/pubmed/35180410
http://dx.doi.org/10.1016/S2214-109X(22)00003-1
_version_ 1784651877685657600
author Kim, Hyun
Manzi, Shannon
Gonzelez-Heydrich, Joseph
Picker, Jonathan
author_facet Kim, Hyun
Manzi, Shannon
Gonzelez-Heydrich, Joseph
Picker, Jonathan
author_sort Kim, Hyun
collection PubMed
description
format Online
Article
Text
id pubmed-8846602
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-88466022022-02-16 Fluvoxamine for the treatment of COVID-19 Kim, Hyun Manzi, Shannon Gonzelez-Heydrich, Joseph Picker, Jonathan Lancet Glob Health Correspondence Elsevier Ltd 2022-03 2022-02-15 /pmc/articles/PMC8846602/ /pubmed/35180410 http://dx.doi.org/10.1016/S2214-109X(22)00003-1 Text en © 2022 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Kim, Hyun
Manzi, Shannon
Gonzelez-Heydrich, Joseph
Picker, Jonathan
Fluvoxamine for the treatment of COVID-19
title Fluvoxamine for the treatment of COVID-19
title_full Fluvoxamine for the treatment of COVID-19
title_fullStr Fluvoxamine for the treatment of COVID-19
title_full_unstemmed Fluvoxamine for the treatment of COVID-19
title_short Fluvoxamine for the treatment of COVID-19
title_sort fluvoxamine for the treatment of covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846602/
https://www.ncbi.nlm.nih.gov/pubmed/35180410
http://dx.doi.org/10.1016/S2214-109X(22)00003-1
work_keys_str_mv AT kimhyun fluvoxamineforthetreatmentofcovid19
AT manzishannon fluvoxamineforthetreatmentofcovid19
AT gonzelezheydrichjoseph fluvoxamineforthetreatmentofcovid19
AT pickerjonathan fluvoxamineforthetreatmentofcovid19